Concussion Active Rehabilitation
Status
Conditions
Treatments
Details and patient eligibility
About
In this study, the investigator plans a randomized trial of active rehabilitation and standard care for acute concussion management. The investigator hypothesizes that patients with acute concussions managed with active rehabilitation will have decreased risk of prolonged concussion symptoms.
Full description
Specific Aims:
To compare the risk of prolonged concussion symptoms (PCS) between an active rehabilitation and a standard care cohort after an acute concussion.
To determine if active rehabilitation compared to routine care reduces the risk of PCS for high-risk patients.
This is a prospective randomized control trial of pediatric patients in the emergency department (ED) diagnosed with an acute concussion. Patients 8-18 years old with an acute concussion diagnosis will be eligible. All patients will receive pedometers to monitor their activity levels. If the patient is in the control group the patient will receive standard concussion management per the treating ED physician. Patients in the active rehabilitation group will receive instructions based on the latest CDC concussion management guidelines that specify a symptom-limited progressive return to full activities. This group will be instructed to take at least 10,000 steps a day for five days on their pedometers.
One to five days after the ED concussion diagnosis a trained research coordinator will call all subjects to reinforce the management plan.
28 to 32 days post ED concussion diagnosis, research assistants will contact subjects via email or phone call to complete the concussion symptoms inventory.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Patient diagnosed with an acute concussion within 48 hours
- Patient greater than 8 and less than 19 years old
Exclusion criteria
- Major psychiatric diagnosis (bipolar disorder, major depression, does NOT include ADHD/ADD)
- Cognitive delay
- GCS < 14
- positive findings on head CT
- Any patient with intracranial surgery, pathology or instrumentation (e.g. VP shunt, brain tumor etc)
Trial design
Primary purpose
Allocation
Interventional model
Masking
55 participants in 2 patient groups
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal